STAGE I SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for STAGE I SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE I SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for STAGE I SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive lymphoma: drug combo shows promise in early trial
Disease control CompletedThis study tested a combination of the drug lenalidomide with standard chemotherapy (called DA-EPOCH-R) in 55 people with a fast-growing type of B-cell lymphoma linked to the MYC gene. The goal was to find the safest dose and see if the combo helps keep the cancer from growing or…
Matched conditions: STAGE I SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 17, 2026 13:55 UTC
-
New combo therapy shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study tested a combination of two drugs, MOR00208 and lenalidomide, in 41 people with chronic lymphocytic leukemia (CLL) or related blood cancers. The goal was to see if the combination could shrink or control the cancer in patients who had not responded to prior treatments …
Matched conditions: STAGE I SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC